CTRI/2023/12/060795
Not yet recruiting
未知
T-ProBNP: a novel predictor of cardiovascular risk in type 2 diabetes - NI
Roche Diagnostics0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
- Sponsor
- Roche Diagnostics
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 2 diabetes mellitus patients with or without cardiovascular disease of either gender.
Exclusion Criteria
- •Subjects who had cancer and renal dysfunction, Pregnancy, Subjects with valvular, rheumatic, and congenital heart disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease.EUCTR2015-000239-34-GBMedical University of Vienna2,400
Completed
Not Applicable
Predictive Value of NT-proBNP on MACEs After Acute Coronary SyndromeAcute Coronary SyndromeST-segment Elevation Myocardial Infarction (STEMI)Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)Major Adverse Cardiac EventsNCT06569511Haseki Training and Research Hospital241
Completed
Phase 4
T-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease a prospective randomized trial<br>diabetes cardiac diseasediabetes mellitus10012653NL-OMON47526Medical university of Vienna200
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-NLMedizinische Universität Wien2,400
Active, not recruiting
Phase 1
Prevention of heart disorders in diabetic patients on the basis of NT-proBNP values.EUCTR2015-000239-34-ATMedizinische Universität Wien2,400